Evidence map›Paper›PMID 38005203›Full record

ReviewMolecules (Basel, Switzerland)2023

Enhanced Antimicrobial Activity through Synergistic Effects of Cold Atmospheric Plasma and Plant Secondary Metabolites: Opportunities and Challenges.

Karthika Prasad, Syamlal Sasi, Janith Weerasinghe, Igor Levchenko, Kateryna Bazaka

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Karthika PrasadSchool of Engineering, College of Engineering, Computing and Cybernetics, The Australian National University, Canberra, ACT 2600, Australia.
Syamlal SasiSchool of Engineering, College of Engineering, Computing and Cybernetics, The Australian National University, Canberra, ACT 2600, Australia.
Janith WeerasingheSchool of Engineering, College of Engineering, Computing and Cybernetics, The Australian National University, Canberra, ACT 2600, Australia.
Igor LevchenkoSchool of Engineering, College of Engineering, Computing and Cybernetics, The Australian National University, Canberra, ACT 2600, Australia.ORCID 0000-0002-8606-6195
Kateryna BazakaSchool of Engineering, College of Engineering, Computing and Cybernetics, The Australian National University, Canberra, ACT 2600, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence of antibiotic resistant microorganisms possesses a great threat to human health and the environment. Considering the exponential increase in the spread of antibiotic resistant microorganisms, it would be prudent to consider the use of alternative antimicrobial agents or therapies. Only a sustainable, sustained, determined, and coordinated international effort will provide the solutions needed for the future. Plant secondary metabolites show bactericidal and bacteriostatic activity similar to that of conventional antibiotics. However, to effectively eliminate infection, secondary metabolites may need to be activated by heat treatment or combined with other therapies. Cold atmospheric plasma therapy is yet another novel approach that has proven antimicrobial effects. In this review, we explore the physiochemical mechanisms that may give rise to the improved antimicrobial activity of secondary metabolites when combined with cold atmospheric plasma therapy.

Indexed as

Anti-Infective AgentsPlasma GasesAnti-Bacterial AgentsHumansAnti-Bacterial AgentsAnti-Infective AgentsPlasma Gasesantibiotic resistancecold atmospheric plasmasecondary metabolites

Identifiers

PMID38005203
PMCPMC10673009

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.